Core Points - The Zhejiang Mingpai Jewelry Co., Ltd. held its first extraordinary general meeting of shareholders in 2025 on November 14, where five important proposals were approved, reflecting shareholders' attention to corporate governance optimization [1][5]. Meeting Overview - The meeting was convened by the board of directors and took place at the company's headquarters in Shaoxing, Zhejiang, combining on-site and online voting methods [2]. - The meeting was presided over by Chairman Yu Awu, with attendance from directors, supervisors, and senior management [2]. Shareholder Attendance - A total of 146 shareholders (including proxies) attended the meeting, representing 281,697,697 shares, which is 53.35% of the total share capital [3]. - Among the attendees, 2 shareholders were present at the on-site meeting, representing 279,694,775 shares (52.97%), while 144 participated via online voting, representing 2,002,922 shares (0.38%) [3]. - Notably, 144 small investors attended, representing 200,290 shares (0.38%), indicating their engagement in corporate governance matters [3]. Proposal Voting Results - All five proposals discussed at the meeting aimed to improve the company's internal governance structure and received high approval rates, with all proposals exceeding 99.7% approval [4]. - The specific approval rates for the proposals were as follows: - Amendment to the Articles of Association: 99.75% [4] - Amendment to the Independent Director Work System: 99.75% [4] - Amendment to the External Guarantee System: 99.72% [4] - Amendment to the Fundraising Management Measures: 99.75% [4] - Amendment to the Related Party Transaction Internal Decision-Making System: 99.75% [4] - The approval rate for small investors was lower for the External Guarantee System amendment at 61.23%, while the other proposals had approval rates above 64% [4]. Legal Opinion - Beijing Junzhi Law Firm provided a legal opinion confirming that the meeting's procedures, attendance, and voting results complied with relevant laws and regulations, deeming the resolutions valid [5]. - The successful convening of the meeting and the related amendments are expected to help Mingpai Jewelry further standardize its operations and enhance governance, laying a foundation for long-term stable development [5].

登录新浪财经APP 搜索【信披】查看更多考评等级 章程专章规定利润分配政策，明确实行"持续稳定、重视回报"的分配原则，现金分红优先于股票股利。 公司实施现金分红需满足三大条件：当年可分配利润为正、审计报告为标准无保留意见、未来12个月无 重大资金支出（超过最近一期经审计总资产30%且超5000万元）。 在分红比例上，公司连续三年以现金方式累计分配利润不少于年均可分配利润的30%，并根据发展阶段 实施差异化政策： - 成熟期且无重大资金支出：现金分红占比不低于80% - 成熟期且有重大资金支出： 现金分红占比不低于40% - 成长期且有重大资金支出：现金分红占比不低于20% 公司设立时发起人包括国创高科实业集团有限公司（原湖北通发科技）、湖北多佳集团实业有限公司等 五家单位及自然人，其中主发起人以实物出资认购4,080万股，其余发起人以现金出资认购3,920万股。 股份由中国证券登记结算有限责任公司深圳分公司集中存管，确保股权登记规范透明。 治理架构与决策机制 章程详细规定了"股东会-董事会-高级管理层"三级治理架构。股东会作为最高权力机构，负责审议利润 分配、增减资、合并分立等重大事项，特别决议需经出席股东所 ...

11月15日，陕西斯瑞新材料股份有限公司（证券简称：斯瑞新材，证券代码：688102）发布2025年第二 次临时股东会决议公告。公司于11月14日召开的本次临时股东会审议通过了续聘年度审计机构、变更注 册资本并修订《公司章程》、修订《募集资金管理制度》等多项核心议案。会议出席股东所持表决权占 公司总表决权的59.6864%，各项议案均获高比例通过，会议程序及表决结果经律师见证合法有效。 《关于修订 <募集资金管理制度> 的议案》（普通决议案） 会议召开及出席情况 本次临时股东会于2025年11月14日在公司4楼会议室召开，由董事会召集，董事长王文斌主持，采取现 场投票与网络投票相结合的方式进行。公告显示，会议召集、召开及表决程序符合《公司法》及《公司 章程》规定。 出席会议的普通股股东及代理人共118人，合计持有表决权435,206,908股，占公司总表决权数量的 59.6864%。公司在任董事7人全部出席会议，董事会秘书王磊及全体高级管理人员列席会议。 多项核心议案高票通过 本次股东会审议的三项非累积投票议案均获通过，具体表决情况如下： 《关于续聘公司2025年度审计机构的议案》（普通决议案） 该议案同意票 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 出品：新浪财经上市公司研究院 文/夏虫工作室 核心观点：科达制造三季报业绩高增，究竟是否值得投资者投资？需要指出的是，公司无实控人公司治 理结构疑遭内部人掏空。一方面，公司出现违规账外收付及核算、发放董监高薪酬等问题；另一方面， 公司关联交易被监管质疑是否存利益输送，需要强调的是，该关联交易毛利率显著低于第三方。 科达制造三季报业绩高增。 三季报显示，公司实现营业收入126.05亿元，同比增长47.19%；归母净利润为11.49亿元，同比增长 63.49%；经营现金流净额为15.60亿元，同比增长65倍。其中，第三季度实现营业收入44.17亿元，同比 增长43.89%；归母净利润4.04亿元，同比增长62.65%。 如此高增的业绩下，公司却遭内部人掏空。与此同时，公司关联交易再次遭监管质疑是否存在利益输 送。 遭内部人掏空？关联交易被质疑利益输送 近期，经中国证券监督管理委员会广东监管局（以下简称"广东监管局"）对科达制造现场检查以及公司 自查，发现公司存在违规账外收付及核算、发放董监高薪酬等问题。 一是，账外收付资金、核算收入费用。 三是，关联方通过供应商短 ...

01 实控人股权司法冻结未及时披露 ST观典实际控制人高明在近一个月的时间内，其所持公司股权接连遭遇司法冻结。这些冻结事项共计 九次，冻结股份占公司总股本比例较高。 然而，高明未能及时将这些司法冻结事项告知上市公司，导致相关信息的披露有所延迟，直至近期才对 外公告。这种未及时履行信息披露义务的行为，直接违反了《上市公司信息披露管理办法》的相关规 定。 登录新浪财经APP 搜索【信披】查看更多考评等级 一家曾被誉为"转板第一股"的明星企业，如今却因实控人股权多次被司法冻结未及时披露而收到监管警 示，公司治理问题再度引发市场关注。 ST观典实际控制人高明近日收到北京证监局出具的警示函行政监管措施决定书，并被记入证券期货市 场诚信档案。这位公司实际控制人在其所持股权经历多次司法冻结后，未能及时履行信息披露义务，这 一行为违反了上市公司监管规定。 上海证券交易所随后也对高明发出了监管警示，这已是ST观典及相关人员近一年来多次收到监管关 注。 公司一度存在虚构应付账款并以保理业务形式为其他公司提供融资便利的情况，导致公司账户资金被划 扣，实际控制人高明自认构成对公司的非经营性资金占用。 更为严重的是，公司治理制衡机制不 ...

关于大湾区上市公司治理状况，课题组通过六大维度、五大板块系统评价并分析得出六条结论：第一， 大湾区上市公司整体治理水平较高，但首次出现回调；第二，大湾区无实际控制人上市公司治理水平最 高，民营控股上市公司治理水平高于国有控股；第三，大湾区上市公司股东治理优势缩小，主要在于关 联交易增加；第四，大湾区上市公司董事会治理优势稳定，但运作效率与组织结构有待优化；第五，大 湾区上市公司监事会治理水平偏低，规模结构与胜任能力存在短板；第六，大湾区主板上市公司治理水 平在区域比较中较高，金融机构治理水平提升较大。 评价报告针对大湾区上市公司治理发展状况提出了相应对策建议，包括：第一，制定并推广大湾区上市 公司治理准则，巩固治理优势并强化示范效应；第二，发挥无实际控制人的治理优势，构建与之相适应 的责任体系；第三，完善中小股东保护机制，强化关联交易监管；第四，弥补监督职能短板，提高审计 委员会独董比例；第五，强化应急治理安排，提高应急响应能力；第六，构建治理导向市值管理体系， 解决选择性披露问题；第七，强化绿色治理（ESG）顶层设计，提升绿色治理（ESG）信息披露质量； 第八，推动大湾区民营控股上市公司完善中国特色现代企业 ...

Core Viewpoint - The divorce settlement between Zhao Bingxian and Lu Juan has resulted in a 50-50 ownership of Zhongzheng Wanrong Investment Group, leading to a governance vacuum for Wohuah Pharmaceutical, which now lacks a controlling shareholder [1] Group 1: Governance Issues - The equal distribution of shares means neither Zhao Bingxian nor Lu Juan can unilaterally control the board or strategic direction, potentially leading to decision-making deadlocks [2] - Key issues such as strategic transformation, major project investments, or executive appointments may become contentious, resulting in governance challenges [2] - Although the company claims that operational management remains unaffected, the dispersed control introduces uncertainty for future stability [2] Group 2: Performance and Growth Concerns - Wohuah Pharmaceutical reported a 179.34% year-on-year increase in net profit for the first three quarters of 2025, primarily driven by non-recurring income from land transfer payments [3] - The core business growth remains weak, with reliance on a limited range of proprietary products amidst increasing regulatory pressures and procurement challenges [3] - The company must address its growth bottlenecks and develop a second growth curve to ensure long-term sustainability [3] Group 3: Industry-Wide Implications - Wohuah Pharmaceutical is not an isolated case; several other companies have faced similar issues due to controlling shareholders' divorces, leading to significant ownership restructuring [4] - These events have raised concerns about the stability of shareholder structures and the management of risks associated with controlling shareholders' personal relationships [4] - As the capital market matures, it is crucial to implement measures such as corporate governance design, equity trusts, and voting rights arrangements to mitigate disruptions caused by personal relationship changes [4] Conclusion - The "no owner" status of Wohuah Pharmaceutical highlights broader governance challenges within A-share companies, emphasizing the need for strategic resilience and operational stability in the face of high volatility and uncertainty in ownership structures [5]

Group 1 - The company held its second temporary board meeting on November 13, 2025, where all 14 directors attended and the meeting was presided over by Chairman Zhou Hongjiang [3][4][6] - The board approved a proposal to change the registered capital and amend the company's articles of association with unanimous support [6][10] - The company has completed a share buyback plan, repurchasing 12,430,000 B shares, which will be canceled, reducing the total shares from 669,670,128 to 657,240,128 and the registered capital from 669,670,128 yuan to 657,240,128 yuan [11][10] Group 2 - The company announced the third temporary shareholders' meeting to be held on December 2, 2025, with a combination of on-site voting and online voting [13][15] - The meeting will allow shareholders who hold shares as of the registration date of November 26, 2025, to participate [16][17] - Detailed voting procedures and registration requirements for shareholders were provided, including the need for identification and proof of shareholding [19][21]

Group 1 - The company has revised several governance systems to enhance its governance structure and ensure compliance with relevant laws and regulations [1][3] - The revised systems include fundraising management, financial management, external financial assistance, and financial reporting management [1] - The revisions were approved during the 25th meeting of the fourth board of directors held on November 13, 2025 [1] Group 2 - The company is conducting a board of directors election due to the expiration of the independent directors' terms [3][4] - The candidates for the fifth board of directors include Liu Fangyi and Jin Zhe as non-independent directors, and Zhang Yanbo and Liu Yuyu as independent directors [3][4] - The election will take place during the third extraordinary shareholders' meeting on December 1, 2025, using a cumulative voting system [5][14] Group 3 - The independent director candidates have passed the qualification review by the Shanghai Stock Exchange [4][6] - The company expresses gratitude to the current board members for their contributions during their tenure [6] - The company will continue to operate under the current board until the new board is elected [6] Group 4 - The third extraordinary shareholders' meeting will be held on December 1, 2025, at 14:00 in Shandong Province [14][15] - Shareholders can vote through both on-site and online systems, with specific voting times outlined [16][20] - The company encourages shareholders to participate via the online voting system for convenience [27]

证券代码：601199 证券简称：江南水务 公告编号：临2025-048 债券代码：252240 债券简称：23江南01 江苏江南水务股份有限公司 第八届董事会第六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 江苏江南水务股份有限公司（以下简称"公司"或"江南水务"）第八届董事会第六次会议于2025年11月13 日在公司三楼会议室（江苏省江阴市滨江扬子江路66号）以现场结合通讯表决的方式召开。本次会议通 知于2025年11月3日以电子邮件等方式向全体董事、高级管理人员发出。会议应到董事9人，实到董事9 人，会议由董事长华锋先生主持，公司高级管理人员列席了会议。会议的召集、召开符合《公司法》及 《公司章程》的有关规定，会议合法有效。 二、董事会会议审议情况 经与会董事认真审议，会议形成决议如下： （一）审议通过了《关于调整董事会专门委员会成员的议案》 鉴于公司董事会人员调整，为完善公司治理结构，保证各专门委员会正常有序开展工作，根据《上市公 司治理准则》、《上海证券交易所上市公司自 ...